Immunovant

Develops monoclonal antibody therapies for patients with autoimmune diseases.

immunovant.comBiotechnology, Pharmaceuticals362 employeesUS
PublicFounded 2018Biopharmaceutical drug developmentClinical trial managementMonoclonal antibody researchAutoimmune disease therapeuticsPharmaceutical research and development
Showing 6 matching jobs
Title
Senior Director, Regulatory Affairs Strategy
Full Time · $270K-$290K · 12+ YOE
North America · Remote
Director, Medical Science Liaison (MSL)
Full Time · $230K-$250K · 3+ YOE
United States · Remote
Vice President, Drug Safety and Pharmacovigilance (DSPV)
Full Time · $400K-$425K · 12+ YOE
United States · Remote
Executive Director, Commercial Operations
Full Time · $290K-$320K · 15+ YOE
New York City or United States · Hybrid
Director, Marketing
Full Time · $210K-$250K · 8+ YOE
United States · Hybrid
Senior Director, Clinical Pharmacology
Full Time · $250K-$305K · 9+ YOE
United States · Remote

About Immunovant

Activities
Biopharmaceutical drug developmentClinical trial managementMonoclonal antibody researchAutoimmune disease therapeuticsPharmaceutical research and development
HeadquartersUS
Industries
BiotechnologyPharmaceuticals
NameImmunovant
Employees362
TypePublic
Parent CompanyRoivant Sciences
Subsidiaries
IMVT Corporation
TaglineDevelops monoclonal antibody therapies for patients with autoimmune diseases.
Founded2,018
Websiteimmunovant.com
Stock ExchangeNASDAQ
Stock SymbolIMVT